BC3202 - Special Topics in Biochemistry and Molecular Biology
| Credit points: | 03 |
| Year: | 2010 |
| Student Contribution Band: | Band 4 |
| Administered by: | School of Pharmacy & Molecular Sciences |
This subject covers a broad range of state-of-the art laboratory techniques used in biochemistry and molecular biology research laboratories through both lectures and laboratory experience. Lectures will cover the use of modern techniques used in biochemistry and molecular biology and experimental design. Students will be required to complete a 96 hours placement (three weeks full time between the 5th July and 23rd July 2010).
Learning Outcomes
- ensure students are able to design, conduct and analyse the results of experiments;
- ensure students are able to reproduce experiments described in a scientific publication;
- ensure students are able to use the web and databases for the efficient analysis of nucleotide and protein sequences;
- ensure students have first hand experience and develop skills in modern techniques used in biochemistry and molecular biology laboratories;
- proficient use of standard statistics and graphics software packages.
| Assumed Knowledge: | BC3101 and BC3102 strongly recommended |
| Prerequisites: | BC2013 AND BC2023 AND BC2024 |
| Inadmissible Subject Combinations: | BC5202 GG3202 |
Availabilities | |
| Townsville, Internal, Study Period 2 | |
| Census Date 26-Aug-2010 | |
| Coordinator: | Professor David Miller |
| Lecturers: | Assoc. Professor Bill Warren, Professor Alan Baxter, Professor Heinrich Korner, Dr Bill Leggat, Dr Patrick Schaeffer, Dr Natalie Pecheniuk, Professor David Miller, Professor James Burnell. |
| Contact hours: |
|
| Assessment: | end of semester exam (30%); presentations (10%); assignments (35%); research project supervisor's mark (15%); laboratory book and tutorial attendance (10%). |
Note: Minor variations might occur due to the continuous Subject quality improvement process, and in case of minor variation(s) in assessment details, the Subject Outline represents the latest official information.